FDA approves low-dose pilocarpine hydrochloride 0.4% as a treatment for presbyopiaByLynda Charters,Emily Kaiser Maharjan, Assistant Managing Editor,Elad Kedar,Paul SmithOctober 18th 2023Qlosi (Orasis Pharmaceuticals) approved to treat presbyopia.
Pipeline: Presbyopia treatment to finish Phase 3 late 2021ByElad Kedar,Gretchyn M. Bailey, NCLC, FAAO, Editor in Chief, Content Channel Director,Brooke Henson, EditorJune 4th 2021Orasis Pharmaceuticals drop in development for treating presbyopia